No significant differences in basal salivary cortisol level between ultra-high risk subjects, first-episode of psychosis and help-seekers.
Meta-analyses show that only cortisol level in UHR was increased compared to controls.
Basal salivary cortisol may not be a valid biomarker for clinical staging/psychotic transition prediction.